Sanofi India Q1 PAT spurts 71% YoY to Rs 146 cr

Image
Capital Market
Last Updated : Apr 27 2021 | 7:55 PM IST

The company's standalone net profit surged 70.84% to Rs 145.90 crore on 7.57% decline in revenue from operations to Rs 725.10 crore in Q1 FY21 over Q1 FY20.

The sales performance for the quarter ended 31 March 2021 is not comparable to 31 March 2020 due to lower export sales on account of transfer of Ankleshwar manufacturing facility in Gujarat during the previous year. Additionally, the sales has also been impacted due to the COVID-19 pandemic.

Sanofi India is one of the entities through which Sanofi operates in India. It offers a wide array of medicines for therapy areas such as diabetes, cardiology, thrombosis, central nervous system and anti-histamines. The products manufactured by the company are distributed in India and exported to many developed as well as developing countries.

Shares of Sanofi India rose 0.62% to Rs 7,484.45 on BSE. The stock traded in the range of Rs 7,427.75 to Rs 7,526.20 so far.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 27 2021 | 3:09 PM IST

Next Story